Lactoferrin is a multifunctional mammalian immunity protein that limits microbial growth through sequestration of nutrient iron. Additionally, lactoferrin possesses cationic protein domains that directly bind and inhibit diverse microbes. The implications for these dual functions on lactoferrin evolution and genetic conflicts with pathogens remain unclear. Here we show that lactoferrin has been subject to recurrent episodes of positive selection during primate divergence predominately at antimicrobial peptide surfaces consistent with long-term antagonism by pathogens. An abundant lactoferrin polymorphism in human populations and Neanderthals also exhibits signatures of positive selection across primates, linking ancient hostmicrobe conflicts to modern human genetic variation. Rapidly evolving sites in lactoferrin further correspond to molecular interfaces with pathogenic bacteria causing meningitis, pneumonia, and sepsis. Because microbes actively target lactoferrin to acquire iron, we propose that the emergence of antimicrobial activity provided a pivotal mechanism of adaptation sparking evolutionary conflicts via acquisition of new protein functions.
INTRODUCTION
Genetic conflicts between microbial pathogens and their hosts are a major source of evolutionary innovation [1] . Selective forces imposed by these antagonistic interactions can give rise to dramatic bouts of adaptive gene evolution through positive selection. J.B.S. Haldane originally speculated on the importance of infectious disease as an "evolutionary agent" over 60 years ago [2] , and the Red Queen hypothesis later posited that predators and their prey (or pathogens and their hosts) must constantly adapt in order to sustain comparative fitness [3, 4] . More recent studies have demonstrated how evolutionary conflicts progress at the single gene or even single nucleotide level, as molecular interfaces between host and microbial proteins can strongly impact virulence and immunity [5] [6] [7] . Host-pathogen interactions thus provide fertile ground for studying rapid gene evolution and acquisition of novel molecular traits [8] .
Lactoferrin presents a compelling model for investigating adaptation from an ancestral "housekeeping" function to a specialized immunity factor. Lactoferrin arose from a duplication of the transferrin gene in the ancestor of eutherian mammals roughly 160 million years ago [9] . A fundamental and shared feature of these proteins is the presence of two evolutionary and structurally homologous iron binding domains, the N and C lobes, each of which chelates a single iron ion with high affinity. Iron binding by these proteins can effectively starve invasive microbes of this crucial metal, a protective effect termed nutritional immunity [10, 11] . Pathogens in turn actively scavenge iron from these and other host proteins in order to meet their nutrient requirements [12, 13] . The importance of iron in human infectious disease is highlighted by genetic disorders of iron overload, such as hereditary hemochromatosis, which render affected individuals highly susceptible to bacterial and fungal infections [14, 15] . In addition to its role in nutritional immunity, lactoferrin has acquired new immune functions independent of iron binding following its emergence in mammals. Lactoferrin is expressed in a variety of body tissues and fluids including breast milk, colostrum, saliva, tears, mucous, as well as the secondary granules of neutrophils and inhibits the growth of many microbes [16] . Portions of the lactoferrin N lobe are highly cationic, facilitating interaction with and disruption of microbial membranes. Two regions of the lactoferrin N lobe in particular, lactoferricin and lactoferrampin, can be liberated from the lactoferrin polypeptide by proteolytic cleavage and exhibit potent antimicrobial activity against bacteria, fungi, and viruses [17, 18] . Lactoferrin, as well as lactoferricin alone, can directly bind the lipid A component of lipopolysaccharide (LPS) as well as lipoteichoic acid, contributing to interactions with surfaces of Gram-negative and Gram-positive bacteria [19, 20] . Lactoferrin thus poses a unique challenge for pathogens -while its ability to bind iron makes it an attractive target for "iron piracy," lactoferrin surface receptors could render these microbes more susceptible to associated antimicrobial activity. Despite a growing appreciation for lactoferrin's immune properties, the evolutionary implications of these unique functions remain unclear. In the present study we decipher recent signatures of natural selection acting on lactoferrin in primates and modern humans to understand the evolutionary consequences of a newly acquired antimicrobial activity from a distinct ancestral function.
RESULTS

Positive selection has shaped the lactoferrin N lobe in primates
To assess the evolutionary history of lactoferrin in primates, we assembled gene orthologs from publicly available databases and cloned lactoferrin complementary DNA (cDNA) prepared from primary cell lines. In total, we compared 15 lactoferrin orthologs from hominoids, Old World, and New World monkeys, representing roughly 40 million years of primate divergence ( Figure 1A , S1). We then used maximum likelihood-based phylogenetic approaches (performed with the PAML and HyPhy software packages) to calculate nonsynonymous to synonymous substation rate ratios (dN/dS) across this gene phylogeny [21] [22] [23] . Complementary tests indicated that lactoferrin has evolved under episodic positive selection in the primate lineage, consistent with a history of host-pathogen evolutionary conflict ( Figure 1A , Supplemental Tables 1-7 ). These findings are also in line with previous genome-wide scans for positive selection in primates which identified the lactoferrin gene (LTF) among others [24] . We next determined signatures of selection across individual codons in lactoferrin. In total, 17 sites displayed strong evidence of positive selection (posterior probability >0.95 from Naïve Empirical Bayes and Bayes Empirical Bayes analyses in PAML), with 13 of the 17 sites found in the N lobe ( Figures 1B, 1C , S1, Supplementary Tables 2, 4 -6) . This observation was notably dissimilar from a parallel analysis of serum transferrin, where sites under positive selection were restricted to the C lobe ( Figure 1B , 1C, Supplementary Table 3 ). These results are further consistent with our previous work indicating that rapid evolution in primate transferrin is likely due to antagonism by the bacterial iron acquisition receptor TbpA, which exclusively binds the transferrin C lobe [25] [26] [27] [28] . Thus, while lactoferrin and transferrin both exhibit signatures of positive selection in primates, patterns of selection across the two proteins are highly discordant.
Evolution and diversity of lactoferrin in modern humans
Evidence of episodic positive selection in primate lactoferrin led us to more closely investigate variation of this gene across human populations. Of the 17 sites we identified as rapidly evolving across primate species, amino acid position 47 overlapped with a high frequency arginine (R) to lysine (K) substitution in the N lobe of lactoferrin found in humans (Figure 2A , Supplementary Tables 8, 9 ). This position is markedly polymorphic between populations; while individuals of African ancestry carry the K47 allele at about 1% frequency, this variant is found in non-African populations at roughly 30-65% allele frequency, with the highest frequencies observed among Europeans ( Figure 2B , Supplementary Table 9 ). The presence of R47 in related great apes combined with its high frequency in African populations suggests that R47 is the ancestral allele in humans, although it is conceivable that long-term balancing selection could also produce such differences. Data from the Neanderthal genome browser (http://neandertal.ensemblgenomes.org) further revealed lysine to be the consensus residue at position 47 in recently sequenced Neanderthals. The presence of the lactoferrin K47 allele in Neanderthal and non-African human populations and its near absence in Africans suggests one of several intriguing genetic models for the history of this variant, including long-term balancing selection, convergent evolution, or introgression from Neanderthals into modern humans.
Given our observed correlations between sites under selection in primates and variation within human populations, we sought to determine whether lactoferrin exhibits signatures of positive selection among modern humans. Calculation of pairwise FST between a subset of human populations identified an elevated signal of differentiation between European (CEU) and African (YRI) populations [29] , consistent with observed differences in allele frequencies between these groups ( Figure S2A ). The FST at rs1126478 was 0.70 (empirical p-value < 0.001), 0.30, and 0.03 for CEU-YRI, CEU-CHB, and CEU-FIN, respectively. Single nucleotide variants neighboring rs1126478 also showed signs of elevated FST suggesting that a shared CEU haplotype was driving the signal of differentiation ( Figure S2A ). We next applied measures of haplotype homozygosity to assess the possibility that the K47 haplotype has been subject to natural selection in humans. Linkage around R47 alleles breaks down within ~10 kilobases, while the K47 variant possesses a markedly extended haplotype, consistent with the possibility of an adaptive sweep in this genomic region (Figure Ch3 Kbp 6 2C). A selective sweep is also consistent with bifurcation plots around position 47, where the K47 haplotypes possess increased homogeneity relative to R47 haplotypes ( Figure 2D ). We observed a slight an elevation of the genome-wide corrected integrated haplotype score (iHS) for the K47 allele (-1.40136) and a depletion of observed heterozygosity ( Figure S2B , S3, S4). We also examined the patterns of cross population extended haplotype homozygosity (XP-EHH). Consistent with the FST and EHH results, the XP-EHH score was elevated at the K47 position when CEU individuals were compared against YRI (1.1; p-value: 0.129) or CHB (3.1; p-value: 0.003)( Figure S5 ). While XP-EHH between CEU and YRI was moderate, surrounding SNPs less than 3 kilobases away had values as high as 2.89 (rs189460549; p-value: 0.01). Genome-wide, the K47 XP-EHH signal is moderate compared to other loci. Next we compared the joint distribution of the p-values from dN/dS analyses [24] with the empirical p-values from the CEU-CHB XP-EHH analyses ( Figure S6 ). The previous genome-wide rank for lactoferrin, from dN/dS analyses, was 226 before considering the joint distribution and 156 after. The top 20 genes with the greatest change in rank (dN/dS p-value < 0.01) include BLK, DSG1, FAS, SLC15A1, GLMN, SULT1C3, WIPF1, and LTF. This meta-analysis highlights genes that have undergone specieslevel as well as population-level selection in primates and humans respectively. By integrating molecular phylogenetic analyses and population genetics approaches, we pinpointed signatures of positive selection associated with an abundant human lactoferrin polymorphism.
Rapid evolution of lactoferrin-derived antimicrobial peptides
Evidence of positive selection in the lactoferrin N lobe among diverse primates, including position 47 in humans, led us to more closely investigate evolutionary pressures that have influenced variation in this region. After gene duplication from ancestral transferrin, lactoferrin gained potent antimicrobial activities independent of iron binding through cationic domains capable of disrupting microbial membranes. Two portions of the lactoferrin N lobe in particular, termed lactoferricin (amino acids 20-67) and lactoferrampin (amino acids 288-304), have been implicated in these antimicrobial functions [18, 30] . Recent reports indicate that the human lactoferrin K47 variant, within the N lobe lactoferricin peptide, may have a protective effect against dental cavities associated with pathogenic bacteria [31] . Moreover, saliva isolated with patients homozygous for the K47 variant possesses enhanced antibacterial activity against oral Streptococci relative to homozygous R47 individuals [32] .
Phylogenetic analysis revealed that several sites corresponding to lactoferricin and lactoferrampin display signatures of positive selection ( Figure 3A, 3B) . Notably, positive selection in lactoferricin localized to sites harboring cationic (lysine, arginine) or polar uncharged residues (asparagine), which could mediate membrane disruption and regulate antimicrobial activity. Position 47, which exhibits signatures of selection in humans as well as other primates, also lies within the lactoferricin peptide region. In contrast, hydrophobic tryptophan residues proposed to mediate insertion into microbial membranes are completely conserved among primates, as are cysteine residues that participate in intramolecular disulfide bond formation ( Figure 3A ). We also observed rapid evolution of the position immediately C-terminal to the cleavage site in lactoferrampin ( Figure 3A ), suggesting that the precise cleavage site in this peptide may be variable among species. Expanding our phylogenetic analysis to other mammalian taxa, we found that lactoferrin also exhibits signatures of positive selection in rodents and carnivores ( Figure S7 , Supplementary Table 10 ). While the specific positions that contribute most strongly to these signatures could not be resolved with high confidence, N-terminal regions corresponding to lactoferricin in primates are absent in several rodent and carnivore transcripts, suggesting that this activity may have been lost or modified in divergent mammals. Together these results demonstrate that lactoferrin-derived cationic peptides of the N lobe are rapidly evolving at sites critical for antimicrobial action. 
Distinct microbial interfaces are subject to positive selection in lactoferrin
While rapid evolution of the lactoferrin N lobe may reflect selection for improved targeting of pathogen surfaces, it could also represent adaptations that prevent binding by inhibitors encoded by pathogens. For example, pneumococcal surface protein A (PspA) is a crucial virulence determinant of Streptococcus pneumoniae, and several studies have demonstrated that PspA specifically binds and inhibits antimicrobial portions of the lactoferrin N lobe [33] . Consistent with an important evolutionary impact for this interaction, numerous sites under positive selection in the lactoferrin N lobe lie proximal to the PspA binding interface [34] , including those corresponding to the lactoferricin peptide ( Figure 3C ). These data suggest that adaptive substitutions in lactoferrin could negate PspA binding, leading to enhanced immunity against S. pneumoniae or related pathogens.
Many strains of pathogenic Neisseria, which cause the sexually transmitted disease gonorrhea as well as acute meningitis, encode lactoferrin binding proteins (LbpA and LbpB) which mediate iron acquisition from lactoferrin [35, 36] . Of four sites identified under positive selection in the lactoferrin C lobe, at least two appear proximal to the proposed Neisseria LbpA binding interface based on recent molecular modeling studies ( Figure S8 ) [37] . One of these, position 589, also aligns to a region under strong positive selection in transferrin (position 576 in humans) which directly contacts the related bacterial receptor TbpA ( Figure 1B) [28] . These findings suggest that, similarly to transferrin, antagonism by bacterial Lbp proteins may have promoted natural selection in the lactoferrin C lobe. Signatures of selection at distinct lactoferrin-pathogen interfaces thus highlight the diverse conflicts that have arisen during the evolution of this unique immunity factor.
DISCUSSION
Together our results suggest that the emergence of novel antimicrobial activity in the N lobe of lactoferrin strongly influenced host-pathogen interactions in primates, including modern humans (Figure 4 ). High disparity in sites under positive selection between the N and C lobes of lactoferrin and transferrin indicate that distinct selective pressures influenced these proteins during primate evolution. We previously demonstrated that primate transferrin has been engaged in recurrent evolutionary conflicts with the bacterial receptor, TbpA [25] . This receptor is an important virulence factor in several Gram-negative human pathogens including Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae, as well as related animal pathogens [26, [38] [39] [40] . Notably, TbpA binds and extracts iron exclusively from the C lobe of transferrin, and signatures of positive selection in transferrin are almost entirely restricted to the TbpA binding interface (Figure 1) [25] . The fact that transferrin family proteins are recurrently targeted by pathogens for iron acquisition may have provided the selective advantage for antimicrobial functions that arose in the lactoferrin N lobe. Following a duplication of the transferrin gene in the ancestor of eutherian mammals, interactions between the transferrin (yellow) C lobe and the bacterial transferrin receptors such as TbpA (green) led to the emergence of a molecular arms race. In contrast, while lactoferrin has likely also been engaged in evolutionary conflicts with pathogen iron acquisition receptors like LbpA (purple), the emergence of antimicrobial peptide activity in the N lobe would have provided novel defense activity against pathogens targeting lactoferrin as an iron source. This function would have led to the emergence of pathogen inhibitors of lactoferrin antimicrobial peptide activity (such as PspA or LbpB), which have dominated subsequent evolutionary conflicts localized to the lactoferrin N lobe.
Our results suggest at least two non-mutually exclusive scenarios for evolutionary conflicts involving the lactoferrin N lobe. Positive selection in this region could reflect adaption of lactoferrin for enhanced targeting of variable pathogen surfaces. Lactoferricin is capable of binding the bacterial LPS, which itself is heavily modified in many pathogens to mediate immune evasion and could provoke counter-adaptations at this interface. Conversely, variation in the lactoferrin N lobe could negate interactions with pathogen inhibitory proteins such as PspA encoded by S. pneumoniae. Lactoferrin binding activity has also been identified in several other important bacterial pathogens including Treponema pallidum [41] , Staphlococcus aureus [42] , and Shigella flexneri [43] , raising the possibility of multiple independent evolutionary conflicts playing out at the lactoferrin N lobe. Iron-loaded lactoferrin could further be viewed as a "Trojan horse," where microbes that target it as a nutrient iron source may be more susceptible to antimicrobial peptides. Consistent with this hypothesis, recent work has suggested that Neisseria encoded LbpB recognizes the lactoferrin N lobe, in contrast to its homolog TbpB which selectively interacts with the iron-loaded C lobe of transferrin [36, 44, 45] . LbpB binding to the lactoferrin N lobe could thus provide a counter-adaptation with dual benefits by neutralizing lactoferrin antimicrobial activity through negatively charged protein surfaces while simultaneously promoting iron acquisition by its co-receptor, LbpA [44] . These observations point to host-pathogen adaptations involving de novo protein functions on both sides of this genetic conflict.
Our results raise the possibility that the lactoferrin K47 variant introgressed into humans from Neanderthals at some point after the out-of-Africa expansion roughly 60,000 years ago [46] . An alternative explanation could be convergent evolution of lactoferrin in distinct lineages of early hominins for enhanced immune function, as well as long term balancing selection. Future analysis of lactoferrin sequence in archaic humans could provide additional insight on the history of this variant. Together these studies provide a direct link between variation in the lactoferrin N lobe and protection against pathogenic bacteria, consistent with adaptive evolution of lactoferrin in humans and other primates.
Notably, the lactoferrin gene, LTF, is located only ~60 kb away from CCR5, a chemokine receptor which is also an entry receptor for HIV [47] [48] [49] [50] [51] . A 32-base pair deletion in CCR5 (CCR5-Δ32) confers resistance to HIV infection, and is present at a high frequency in northern Europeans while absent from African populations [52] . Although early evidence suggested that CCR5-Δ32 might itself be subject to positive selection in humans, more recent studies have concluded that these signatures are more consistent with neutral evolution [53] . It is intriguing that, like CCR5-Δ32, the lactoferrin K47 variant exhibits increased allele frequency in European populations relative to Africans. However, the presence of the K47 variant at high frequencies in Asian and American populations points to a much earlier origin for this variant than CCR5-Δ32. Moreover, EHH and bifurcation analyses indicate that the haplotypes associated with the lactoferrin K47 variant do not encompass CCR5, suggesting that variation at the CCR5 locus is unlikely to contribute to signatures of selection in LTF ( Figure 2B, 2C, Supplementary Table 9 ). The proximity of the LTF and CCR5 genes combined with their high degree of polymorphism and shared roles in immunity suggest the potential for genetic interactions relating to host defense. Future studies could reveal functional or epidemiological links between these two factors in human immunity.
In summary, we have discovered that lactoferrin constitutes a crucial node of hostpathogen evolutionary conflict based on signatures of natural selection across primates, including modern humans. Our findings suggest an intriguing mechanism for molecular arms race dynamics where adaptations and counter-adaptations rapidly emerge at the level of new protein functions in addition to recurrent amino acid substitutions at a single protein interface (Figure 4 ). Duplication and neofunctionalization of gene paralogs carries the potential to drastically alter the outcome of genetic conflicts. Our evolutionary analyses highlighting consequences of lactoferrin diversity pinpoint critical genetic variants to pursue in the fight against modern infectious diseases.
MATERIALS & METHODS
Primate genetic sources. RNA was obtained from the following species via the Coriell Cell Repositories where sample codes are indicated: Homo sapiens (human; primary human foreskin fibroblasts; gift from A. Geballe), Gorilla gorilla (western lowland gorilla; AG05251), Papio anubis (olive baboon; PR00036), Lophocebus albigena (grey-cheeked mangabey; PR01215), Cercopithecus aethiops (African green monkey; PR01193), Colobus guereza (colobus monkey; PR00240), Callithrix geoffroyi (white-fronted marmoset; PR00789), Lagothrix lagotricha (common woolly monkey; AG05356), Saimiri sciureus (common squirrel monkey; AG05311). Gene sequences from additional primate, rodent, and carnivore species were obtained from Genbank.
cDNA cloning and sequencing. RNA (50 ng) from each primate cell line was prepared (RNeasy kit; Qiagen) and used as template for RT-PCR (SuperScript III; Invitrogen). Primers used to amplify lactoferrin cDNA were as follows: GTGGCAGAGCCTTCGTTTGCC (LF-forward; oMFB256) and GACAGCAGGGAATTGTGAGCAGATG (LF-rev; oMFB313). PCR products were TA-cloned into pCR2.1 (Invitrogen) and directly sequenced from at least three individual clones. Gene sequences have been deposited in Genbank (KT006751 -KT006756).
Phylogenetic analyses and structural observations. DNA multiple sequence alignments were performed using MUSCLE and indels were manually trimmed based on amino-acid comparisons. A generally accepted primate species phylogeny [54] ( Figure 1A) was used for evolutionary analysis. A gene tree generated from the alignment of lactoferrin corresponded to this species phylogeny (PhyML; http://atgc.lirmm.fr/phyml/). Maximum-likelihood analysis of the lactoferrin and transferrin data sets was performed with codeml of the PAML software package [21] . A free-ratio model allowing dN/dS (omega) variation along branches of the phylogeny was employed to calculate dN/dS values between lineages. Two-ratio tests were performed using likelihood models to compare all branches fixed at dN/dS=1 or an average dN/dS value from the whole tree applied to each branch to varying dN/dS values according to branch.
Positive selection in lactoferrin was assessed by fitting the multiple alignment to either F3X4 or F61 codon frequency models. Likelihood ratio tests (LRTs) were performed by comparing pairs of site-specific models (NS sites): M1 (neutral) with M2 (selection), M7 (neutral, beta distribution of dN/dS<1) with M8 (selection, beta distribution, dN/dS>1 allowed). Additional LRTs from the HyPhy software package that also account for synonymous rate variation and recombination (FUBAR, REL, FEL, MEME, BUSTED) were performed [22, 23] . Molecular structures of lactoferrin, transferrin and associated proteins were visualized using Chimera (http://www.cgl.ucsf.edu/chimera/).
Human population genetics analysis.
For variant-based analyses we used genotype calls from the 1000 Genomes project (release: 20130502, shapeit2 phased). Weir and Cockerham's Fst estimator [29] was used for the population comparisons, implemented in GPAT++. EHH and the bifurcation diagrams were calculated using the [R] package REHH [55] . Genome-wide iHS1 scans were performed using GPAT++ and XPEHH plots were generated previously published datasets [56, 57] . Figure S1 . A. Phylogeny for primate lactoferrin gene (LTF) inferred using PhyML with the LG substitution model. Bootstrap values are indicated at branch nodes. Astericks denotes orientation of New World monkeys, which differs slightly from the accepted species phylogeny ( Figure  1A) . B. Sites identified under positive selection using PAML and HyPhy analyses. Positions identified by at least two separate tests for selection are indicated. * likelihood score ** degrees of freedom, equal to one less than the total number of branches in the phylogeny. Supplementary Table 2 . Summary of positive selection in primate lactoferrin using PAML. Analyses were performed using two independent codon models (F3X4, F61) which describe the frequency and rate of substitutions. Selection was inferred by comparing likelihood scores between models that allow for selection (M2, M8) relative models which exclude selection (M1, M7) in this gene.
Codon freq. Supplementary Table 3 . Summary of positive selection in primate transferrin using PAML. Analyses were performed using two independent codon models (F3X4, F61) which describe the frequency and rate of substitutions. Selection was inferred by comparing likelihood scores between models that allow for selection (M2, M8) relative models which exclude selection (M1, M7) in this gene.
M1-M2 M7-M8
Codon freq. Supplementary Table 4 . Lactoferrin whole gene log likelihood scores and parameter estimates for four models of variable ω among sites assuming the F3X4 model of codon frequencies (PAML). Amino acid positions shown are for human lactoferrin. Q40  K47  P52  E70  R105  R139  T158  G183  S210  E245  Q292  K304  P331  T465  A588  M622  Q654 -6258.92 * posterior probabilities >0.95 by both Naïve Empirical Bayes (NEB) and Bayes Empirical Bayes analysis. ** ω = dN/dS Supplementary Table 5 . Summary of positive selection in primate lactoferrin (MEME, FEL). Amino acid positions shown are for human lactoferrin. Supplementary Table 10 . Summary of positive selection in rodent and carnivore lactoferrin using PAML. Analyses were performed using two independent codon models (F3X4, F61). Selection was inferred by comparing likelihood scores between models that allow for selection (M2, M8) relative models which exclude selection (M1, M7) in this gene. Tree length and dN/dS values are shown for the M8 calculations.
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